Nov 15, 2024, 09:20 AM by

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Nov 14, 2024, 08:42 AM by

2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.

Nov 14, 2024, 08:42 AM by

SynbiCITE, the U.K.’s National Industrial Translation Centre for Engineering Biology, has been awarded a grant of £3m to expand its Proof-of-Concept (PoC) programme for start-up engineering biology companies.

Nov 14, 2024, 08:42 AM by

Nov 14, 2024, 01:00 AM by User Not Found

Bio-IT World | Investigators at Weill Cornell Medicine have combined several powerful technologies to reconstruct how cancer spreads from the prostate to metastatic sites elsewhere in the body. Bioluminescence imaging, CRISPR/Cas9-based barcoding, and innovative computational methods for tracing the movement of cancer from tissue to tissue were used in creating a roadmap revealing the small number of aggressive cells that seed cancer’s often deadly migration.

Nov 13, 2024, 08:41 AM by

Nov 13, 2024, 08:41 AM by

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Nov 13, 2024, 08:41 AM by

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

Nov 13, 2024, 08:41 AM by

Ansa Biotechnologies just announced that it can deliver its Clonal DNA product in lengths up to 5kb. The longer constructs are made possible due to a new proprietary, sequence-agnostic assembly technology. The complete platform allows Ansa to produce long, complex DNA more accurately and reliably than any other DNA synthesis vendor.

Nov 13, 2024, 08:41 AM by

CG Life, a leading integrated agency that blends strategy, creative, marketing, digital, and communications with science, has welcomed Allison Davis to the agency’s newly created role of Chief Client Officer.

Nov 13, 2024, 01:00 AM by User Not Found

Bio-IT World | The spliceosome, the cellular machinery that catalyzes the process of splicing in genes, was discovered nearly five decades ago and has been successfully leveraged in the development of therapies for rare diseases such as spinal muscular dystrophy where concerns about side effects tend to be secondary to correcting the underlying pathology. The question now is how to move the strategy to more complex diseases involving more than a single gene and splicing mutation.

Nov 12, 2024, 08:16 AM by

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

Nov 12, 2024, 08:16 AM by

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients. This breakthrough enables precise segmentation of DKD patients by disease trajectory over time, marking a pivotal advancement in precision medicine for DKD. MultiOmic’s CEO Robert Thong will present these findings at the LSX Investival Conference in London on 18th November 2024.

Nov 12, 2024, 08:16 AM by

Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and IamFluidics, a leader in microparticle innovation, today announced the launch of a novel research grade dissolvable microcarrier for adherent cell culturing. The product is designed to streamline and scale-up processes for advanced cell therapies, biologics manufacturing and cultured meat production.

Nov 12, 2024, 08:16 AM by

Nov 12, 2024, 01:00 AM by User Not Found

Bio-IT World | In recent research, scientists at the University of Arizona have developed a diagnostic tool, the MeCo Score, which evaluates metastatic risk in early-stage breast cancer by analyzing how cancer cells respond to the stiffness of surrounding tissue. This tool leverages RNA sequencing data from tumor samples to identify a "mechanical conditioning" (MeCo) signature, giving insights into cancer cell adaptations within the tumor microenvironment.

Nov 11, 2024, 08:25 AM by

AppOmni, the leader in SaaS security today announced a significant partnership that combines the company’s Zero Trust Posture Management (ZTPM) solution with Cisco’s Security Service Edge (SSE) technology suite to enable zero trust principles at the application layer in Security-as-a-Service (SaaS) applications.

Nov 8, 2024, 01:00 AM by User Not Found

Bio-IT World | For AI and data-driven drug discovery to have a tangible impact on R&D success, a change in the culture is as important as any investment at a data, model, and validation level. Until quite recently, the perceived value of AI in drug discovery and development failed to match the hype.

Nov 7, 2024, 10:45 AM by

UK-based pharma strategic consultancy, The MAP Group has acquired market access and pricing consultancy, SKC Beratungsgesellschaft mbH as it continues to expand internationally.

Nov 7, 2024, 01:00 AM by User Not Found

Bio-IT World | This week at the American Society of Human Genetics meeting, Pacific Biosciences unveiled both its new SPRQ chemistry—pronounced “spark”— and its newest sequencing platform, Vega, a desktop, long-read sequencer with all the compute on board. Also it’s pink.